MRA Advisory Group’s Sanofi SNY Stock Holding History

MRA Advisory Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,864	Closed	-$334K	–	115
2020 Q4	$334K	Buy	+6,864	New	+$339K	0.33%	63

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MRA Advisory Group's SNY Position: Q1 2021 in Review

MRA Advisory Group sold out of Sanofi (SNY) in Q1 2021, closing a stake of 6,864 shares — an estimated $334K sold.

MRA Advisory Group first reported a position in SNY in Q4 2020 and held it in 1 quarter. The position peaked at $334K in Q4 2020. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

MRA Advisory Group reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
MRA Advisory Group sold 6,864 Sanofi shares in Q1 2021, an estimated $334K.
MRA Advisory Group first reported a position in Sanofi in Q4 2020 and held it in 1 quarter.
MRA Advisory Group's Sanofi position peaked at $334K in Q4 2020.
572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on MRA Advisory Group's 13F filing for Q1 2021, filed 4 May 2021.